{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:34:06Z","timestamp":1790022846302,"version":"4.0.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T00:00:00Z","timestamp":1666137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015528","name":"Universidad de La Laguna","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015528","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.biopha.2022.113909","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T02:32:14Z","timestamp":1666319534000},"page":"113909","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["New local ganirelix sustained release therapy for uterine leiomyoma. Evaluation in a preclinical organ model"],"prefix":"10.1016","volume":"156","author":[{"given":"Ana","family":"Salas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Garc\u00eda-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"D\u00edaz-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"\u00c9vora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa A.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7045-6933","authenticated-orcid":false,"given":"Araceli","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.biopha.2022.113909_bib1","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMcp1411029","article-title":"Clinical practice. Uterine fibroids, The","volume":"372","author":"Stewart","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.biopha.2022.113909_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ijgo.13102","article-title":"Epidemiology and management of uterine fibroids","volume":"149","author":"Giuliani","year":"2020","journal-title":"Int. J. Gynaecol. Obstet.: Off. Organ Int. Fed. Gynaecol. Obstet."},{"issue":"1","key":"10.1016\/j.biopha.2022.113909_bib3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.rbmo.2021.03.013","article-title":"Fibroids and natural fertility: a systematic review and meta-analysis","volume":"43","author":"Somigliana","year":"2021","journal-title":"Reprod. Biomed. Online"},{"issue":"3","key":"10.1016\/j.biopha.2022.113909_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.12.002","article-title":"The estimated annual cost of uterine leiomyomata in the United States","volume":"206","author":"Cardozo","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.biopha.2022.113909_bib5","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1073\/pnas.1518752113","article-title":"Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers","volume":"113","author":"Mehine","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2022.113909_bib6","doi-asserted-by":"crossref","first-page":"2414609","DOI":"10.1155\/2018\/2414609","article-title":"Review of the pharmacologic management of uterine leiomyoma","volume":"2018","author":"Lewis","year":"2018","journal-title":"BioMed. Res. Int."},{"issue":"4544","key":"10.1016\/j.biopha.2022.113909_bib7","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1126\/science.6280278","article-title":"Pituitary receptor site blockade by a gonadotropin-releasing hormone antagonist in vivo: mechanism of action","volume":"216","author":"Heber","year":"1982","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biopha.2022.113909_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/humupd\/dmx032","article-title":"Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics","volume":"24","author":"Islam","year":"2018","journal-title":"Hum. Reprod. Update"},{"issue":"1","key":"10.1016\/j.biopha.2022.113909_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajog.2020.07.032","article-title":"Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids","volume":"224","author":"Al-Hendy","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.biopha.2022.113909_bib10","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJMoa2008283","article-title":"Treatment of uterine fibroid symptoms with relugolix combination therapy","volume":"384","author":"Al-Hendy","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.biopha.2022.113909_bib11","first-page":"E227","article-title":"GnRH membrane binding: identification, specificity, and quantification in nonpituitary tissues","volume":"235","author":"Heber","year":"1978","journal-title":"Am. J. Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2022.113909_bib12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.yfrne.2003.10.003","article-title":"The biology of gonadotropin hormone-releasing hormone: role in the control of tumor growth and progression in humans","volume":"24","author":"Limonta","year":"2003","journal-title":"Front. Neuroendocrinol."},{"issue":"5","key":"10.1016\/j.biopha.2022.113909_bib13","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1530\/REP-08-0397","article-title":"GnRH signaling in intrauterine tissues","volume":"137","author":"Wu","year":"2009","journal-title":"Reproduction"},{"issue":"3","key":"10.1016\/j.biopha.2022.113909_bib14","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/S0006-291X(88)80430-3","article-title":"Gonadotropin-releasing hormone specific binding sites in uterine leiomyomata","volume":"152","author":"Wiznitzer","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.biopha.2022.113909_bib15","first-page":"3215","article-title":"Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro, The","volume":"81","author":"Chegini","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.biopha.2022.113909_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/molehr\/3.2.91","article-title":"Effects of a GnRH analogue on human smooth muscle cells cultured from normal myometrial and from uterine leiomyomal tissues","volume":"3","author":"Kobayashi","year":"1997","journal-title":"Mol. Hum. Reprod."},{"issue":"3","key":"10.1016\/j.biopha.2022.113909_bib17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1530\/eje.0.1460447","article-title":"Down-regulation of proliferation and up-regulation of apoptosis by gonadotropin-releasing hormone agonist in cultured uterine leiomyoma cells","volume":"146","author":"Wang","year":"2002","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113909_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.fertnstert.2006.11.098","article-title":"Human myometrium and leiomyomas express gonadotropin-releasing hormone 2 and gonadotropin-releasing hormone 2 receptor","volume":"88","author":"Parker","year":"2007","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.biopha.2022.113909_bib19","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/521313","article-title":"Receptors of hypothalamic-pituitary-ovarian-axis hormone in uterine myomas","volume":"2014","author":"Plewka","year":"2014","journal-title":"BioMed. Res. Int."},{"issue":"2","key":"10.1016\/j.biopha.2022.113909_bib20","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1210\/jc.2004-1591","volume":"90","author":"Chen","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.biopha.2022.113909_bib21","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.fertnstert.2012.07.1123","article-title":"Gonadotropin-releasing hormone (GnRH) agonist leuprolide acetate and GnRH antagonist cetrorelix acetate directly inhibit leiomyoma extracellular matrix production","volume":"98","author":"Britten","year":"2012","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.biopha.2022.113909_bib22","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.3892\/or.2015.3767","article-title":"Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer","volume":"33","author":"Imamura","year":"2015","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2022.113909_bib23","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.fertnstert.2015.09.006","article-title":"Gonadotropin-releasing hormone analogues inhibit leiomyoma extracellular matrix despite presence of gonadal hormones","volume":"105","author":"Malik","year":"2016","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.biopha.2022.113909_bib24","doi-asserted-by":"crossref","unstructured":"P.S. Gillies, D. Faulds, J.A. Balfour, C.M. Perry, Ganirelix, Drugs 59(1) (2000) 107\u201311; discussion 112\u20133.","DOI":"10.2165\/00003495-200059010-00007"},{"issue":"5","key":"10.1016\/j.biopha.2022.113909_bib25","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1471-0528.2004.00504.x","article-title":"Rapid reduction of leiomyoma volume during treatment with the GnRH antagonist ganirelix","volume":"112","author":"Flierman","year":"2005","journal-title":"BJOG: Int. J. Obstet. Gynaecol."},{"issue":"9","key":"10.1016\/j.biopha.2022.113909_bib26","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1007\/s43032-021-00573-8","article-title":"Trial to assess safety and tolerability of injectable collagenase in women with symptomatic uterine fibroids","volume":"28","author":"Singh","year":"2021","journal-title":"Reprod. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2022.113909_bib27","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.1038\/s41598-020-62158-w","article-title":"Organotypic culture as a research and preclinical model to study uterine leiomyomas","volume":"10","author":"Salas","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2022.113909_bib28","article-title":"Alginate-hydrogel versus alginate-solid system. Efficacy in bone regeneration in osteoporosis, Materials science & engineering","volume":"115","author":"Garcia-Garcia","year":"2020","journal-title":"C., Mater. Biol. Appl."},{"issue":"3\u20134","key":"10.1016\/j.biopha.2022.113909_bib29","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ejps.2013.07.003","article-title":"rhEGF-loaded PLGA-Alginate microspheres enhance the healing of full-thickness excisional wounds in diabetised Wistar rats","volume":"50","author":"Gainza","year":"2013","journal-title":"Eur. J. Pharm. Sci.: Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.biopha.2022.113909_bib30","first-page":"251","article-title":"PLGA\/alginate composite microspheres for hydrophilic protein delivery, Materials science & engineering","volume":"56","author":"Zhai","year":"2015","journal-title":"C., Mater. Biol. Appl."},{"issue":"1","key":"10.1016\/j.biopha.2022.113909_bib31","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1080\/10717544.2020.1815896","article-title":"Long-term sustained release Poly(lactic-co-glycolic acid) microspheres of asenapine maleate with improved bioavailability for chronic neuropsychiatric diseases","volume":"27","author":"Zhai","year":"2020","journal-title":"Drug Deliv."},{"issue":"4","key":"10.1016\/j.biopha.2022.113909_bib32","doi-asserted-by":"crossref","DOI":"10.1088\/1748-6041\/10\/4\/045008","article-title":"BMP-2, PDGF-BB, and bone marrow mesenchymal cells in a macroporous beta-TCP scaffold for critical-size bone defect repair in rats","volume":"10","author":"Del Rosario","year":"2015","journal-title":"Biomed. Mater."},{"issue":"1","key":"10.1016\/j.biopha.2022.113909_bib33","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejpb.2009.04.014","article-title":"VEGF-controlled release within a bone defect from alginate\/chitosan\/PLA-H scaffolds","volume":"73","author":"De la Riva","year":"2009","journal-title":"Eur. J. Pharm. Biopharm.: Off. J. Arb. fur Pharm. Verfahr. e. V."},{"key":"10.1016\/j.biopha.2022.113909_bib34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejpb.2016.11.013","article-title":"Tumor tissue slice cultures as a platform for analyzing tissue-penetration and biological activities of nanoparticles","volume":"112","author":"Merz","year":"2017","journal-title":"Eur. J. Pharm. Biopharm.: Off. J. Arb. fur Pharm. Verfahr. e. V."},{"issue":"12","key":"10.1016\/j.biopha.2022.113909_bib35","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/molbev\/mst197","article-title":"MEGA6: molecular evolutionary genetics analysis version 6.0","volume":"30","author":"Tamura","year":"2013","journal-title":"Mol. Biol. Evol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113909_bib36","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ygyno.2014.04.012","article-title":"A high-throughput open-array qPCR gene panel to identify housekeeping genes suitable for myometrium and leiomyoma expression analysis","volume":"134","author":"Almeida","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.biopha.2022.113909_bib37","unstructured":"J.A. Kiernan, Histological and histochemical methods: Theory and practice, Banbury, UK, 2015."},{"key":"10.1016\/j.biopha.2022.113909_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2017.170","article-title":"Protocols and characterization data for 2D, 3D, and slice-based tumor models from the PREDECT project","volume":"4","author":"de Hoogt","year":"2017","journal-title":"Sci. data"},{"key":"10.1016\/j.biopha.2022.113909_bib39","first-page":"17187","volume":"5","author":"Davies","year":"2015","journal-title":", Capturing Complex Tumour Biol. Vitr.: Histol. Mol. Character Precis. Cut. slices, Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2022.113909_bib40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jss.2006.07.034","article-title":"Screening and detection of apoptosis, The","volume":"139","author":"Huerta","year":"2007","journal-title":"J. Surg. Res."},{"issue":"4","key":"10.1016\/j.biopha.2022.113909_bib41","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2559.2001.01300.x","article-title":"Recent advances in the pathology of smooth muscle tumours of the uterus","volume":"39","author":"Wilkinson","year":"2001","journal-title":"Histopathology"},{"issue":"18","key":"10.1016\/j.biopha.2022.113909_bib42","doi-asserted-by":"crossref","first-page":"8352","DOI":"10.1073\/pnas.0907676107","article-title":"Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors","volume":"107","author":"Vaira","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2022.113909_bib43","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12885-016-2119-2","article-title":"Tumor slice culture system to assess drug response of primary breast cancer","volume":"16","author":"Naipal","year":"2016","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.biopha.2022.113909_bib44","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.pan.2018.09.009","article-title":"Organotypic slice cultures of pancreatic ductal adenocarcinoma preserve the tumor microenvironment and provide a platform for drug response","volume":"18","author":"Lim","year":"2018","journal-title":"Pancreatol.: Off. J. Int. Assoc. Pancreatol."},{"issue":"19","key":"10.1016\/j.biopha.2022.113909_bib45","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/jnci\/djm135","article-title":"Drug resistance and the solid tumor microenvironment","volume":"99","author":"Tredan","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.biopha.2022.113909_bib46","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/humrep\/15.2.245","article-title":"Local tolerance, pharmacokinetics, and dynamics of ganirelix (Orgalutran) administration by Medi-Jector compared to conventional needle injections","volume":"15","author":"Oberye","year":"2000","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.biopha.2022.113909_bib47","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1080\/10717544.2021.1938756","article-title":"PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application","volume":"28","author":"Su","year":"2021","journal-title":"Drug Deliv."},{"issue":"5","key":"10.1016\/j.biopha.2022.113909_bib48","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1210\/er.2012-1014","article-title":"GnRH receptors in cancer: from cell biology to novel targeted therapeutic strategies","volume":"33","author":"Limonta","year":"2012","journal-title":"Endocr. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2022.113909_bib49","first-page":"321","article-title":"The biology of gonadotroph regulation, Current opinion in endocrinology","volume":"16","author":"Ciccone","year":"2009","journal-title":"Diabetes, Obes."},{"issue":"1","key":"10.1016\/j.biopha.2022.113909_bib50","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/(SICI)1097-0142(19960101)77:1<132::AID-CNCR22>3.0.CO;2-5","article-title":"Evidence for coupling of phosphotyrosine phosphatase to gonadotropin-releasing hormone receptor in ovarian carcinoma membrane","volume":"77","author":"Imai","year":"1996","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2022.113909_bib51","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1006\/frne.2001.0217","article-title":"Hypothalamic hormones and cancer","volume":"22","author":"Schally","year":"2001","journal-title":"Front. Neuroendocrinol."},{"issue":"20","key":"10.1016\/j.biopha.2022.113909_bib52","doi-asserted-by":"crossref","first-page":"7533","DOI":"10.1158\/0008-5472.CAN-04-1360","article-title":"Gonadotropin-releasing hormone (GnRH) antagonists promote proapoptotic signaling in peripheral reproductive tumor cells by activating a Galphai-coupling state of the type I GnRH receptor","volume":"64","author":"Maudsley","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2022.113909_bib53","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fendo.2017.00187","article-title":"The role of gonadotropin-releasing hormone in cancer cell proliferation and metastasis","volume":"8","author":"Grundker","year":"2017","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113909_bib54","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1152\/ajpcell.00327.2011","article-title":"Tonicity-independent regulation of the osmosensitive transcription factor TonEBP (NFAT5)","volume":"302","author":"Halterman","year":"2012","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"7","key":"10.1016\/j.biopha.2022.113909_bib55","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.fertnstert.2011.03.084","article-title":"Gonadotropin-releasing hormone agonist increases expression of osmotic response genes in leiomyoma cells","volume":"95","author":"McCarthy-Keith","year":"2011","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.biopha.2022.113909_bib56","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/1933719118816836","article-title":"Ulipristal acetate mediates decreased proteoglycan expression through regulation of nuclear factor of activated T-cells (NFAT5)","volume":"26","author":"Britten","year":"2019","journal-title":"Reprod. Sci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222012987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222012987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:12:15Z","timestamp":1778242335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222012987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":56,"alternative-id":["S0753332222012987"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113909","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New local ganirelix sustained release therapy for uterine leiomyoma. Evaluation in a preclinical organ model","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113909","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113909"}}